Curaleaf (OTCMKTS:CURLF) Announces Earnings Results

Curaleaf (OTCMKTS:CURLF) posted its earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.02, Zacks reports. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.

Curaleaf Stock Up 10.5%

CURLF traded up $0.96 on Tuesday, reaching $10.12. 441,775 shares of the stock were exchanged, compared to its average volume of 145,527. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.73 and a current ratio of 1.52. The company’s 50-day moving average price is $9.55 and its 200 day moving average price is $8.30. Curaleaf has a fifty-two week low of $5.40 and a fifty-two week high of $15.15.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CURLF. UBS Group set a $6.00 price objective on Curaleaf in a research report on Monday, October 5th. Citigroup restated a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Finally, Zacks Research cut shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Curaleaf has a consensus rating of “Buy” and an average target price of $6.00.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted.